scispace - formally typeset
T

Theo M. Luider

Researcher at Erasmus University Rotterdam

Publications -  216
Citations -  8081

Theo M. Luider is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Mass spectrometry & Medicine. The author has an hindex of 46, co-authored 191 publications receiving 7253 citations. Previous affiliations of Theo M. Luider include Instituto Nacional de Saúde Dr. Ricardo Jorge & University of Texas Southwestern Medical Center.

Papers
More filters
Journal ArticleDOI

Gene expression profiles associated with treatment response in oligodendrogliomas

TL;DR: This study is the first to correlate gene expression with chromosomal aberrations and clinical performance (response to treatment and survival) in oligodendrogliomas and identify patient subgroups with good prognosis and those that will benefit from chemotherapeutic treatments.
Journal ArticleDOI

Exosomal Secretion of Cytoplasmic Prostate Cancer Xenograft-derived Proteins

TL;DR: Although their function is not clearly defined cancer-derived exosomes offer possibilities for the identification of novel biomarkers for PCa, they are suggested to have potential in finding novel markers for prostate cancer.
Journal ArticleDOI

Circulating glioma biomarkers

TL;DR: This review highlights various categories of tumor-associated circulating biomarkers identified in blood and cerebrospinal fluid of glioma patients, including circulating tumor cells, exosomes, nucleic acids, proteins, and oncometabolites.
Journal ArticleDOI

Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets.

TL;DR: In immunocompromised ferrets infected with H1N1 pandemic virus, oseltamivir therapy still proved to be partially protective in animals infected with resistant virus, and all ferrets showed prolonged virus shedding.
Journal ArticleDOI

Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors.

TL;DR: The combination of 2D PAGE and MALDI-TOF-MS is successful as an unbiased global screening tool for CSF and identified 2 candidate tumor-related proteins, N-myc oncoprotein and low-molecular weight caldesmon (l-CaD), in CSF samples of patients with primary brain tumors.